Erlerlab Nov 2016
We have been awarded a Pre-Seed grant by the Novo Nordisk Foundation
The majority of cancer deaths are caused when a primary cancer spreads to different parts of the body, so for a long time we have been interested in preventing this spread (called metastasis). The Novo Nordisk Foundation pre-seed grants are exploratory funds to develop new and life-saving technologies, and the foundation has awarded us a grant to develop new anti-metastatic therapies.
This exciting project means we’ll be recruiting a talented postdoc to join our team. If you’d like to know more information at this early stage, please get in touch (email@example.com)